Pyrosequencing in uro-oncology: Applications in prostate cancer;Pyrosequenzierung in der Uroonkologie: Anwendungsmöglichkeiten am Beispiel des Prostatakarzinoms

Urologe - Ausgabe A

Volumn 49, Issue 11, 2010, Pages 1356-1364

  Stadler, T C ^a   Jung, A ^b   Schlenker, B ^a   Nuhn, P ^a   Ellinger, J ^c   Kirchner, T ^b   Stief, C G ^a   Bastian, P J ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Biomarkers; Epigenetics; Methylation; Prostate cancer; Pyrosequencing

Indexed keywords

CANCER DIAGNOSIS; CARCINOGENESIS; EPIGENETICS; GENE SEQUENCE; HUMAN; METHYLATION; PROSTATE CANCER; PYROSEQUENCING; REVIEW;

DNA MUTATIONAL ANALYSIS; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MALE; MEDICAL ONCOLOGY; PROSTATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL; UROLOGY;

EID: 78650216456     PISSN: 03402592     EISSN: 14330563     Source Type: Journal    
DOI: 10.1007/s00120-010-2426-1     Document Type: Review

References (35)

1. Bastian PJ, Yegnasubramanian S, Palapattu GS et al (2004) Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Eur Urol 46:698-708 (Pubitemid 39488398)
2. Chung W, Kwabi-Addo B, Ittmann M et al (2008) Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling. PLoS One 3(4):2079
3. Damaraju S, Murray D, Dufour J et al (2006) Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res 12:2545-2554
4. Dobosy Jr, Roberts JL, Fu VX et al (2007) The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol 177:822-831
5. Draisma G, Etzioni R, Tsodikov A et al (2009) Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 101:374-383
6. Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148-1159
7. Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Ann Rev Biochem 74:481-514
8. Harden SV, Sanderson H, Goodman SN et al (2003) Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies. J Natl Cancer Inst 95:1634-1637
9. He M, Vanaja DK, Karnes RJ et al (2009) Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells. Prostate 69(15):1643-1650
10. Heijnsdijk EA, der Kinderen A, Wever EM et al (2009) Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer. Br J Cancer 101:1833-1838
11. Herman JG, Baylin SB (2001) Methylation-specific PCR. Curr Protoc Hum Genet Chapter 10:16
12. Jeronimo C, Usadel H, Henrique R et al (2001) Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93:1747-1752
13. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428
14. Kibel AS, Jin CH, Klim A et al (2008) Association between polymorphisms in cell cycle genes and advanced prostate carcinoma. Prostate 68:1179-1186
15. Kittles RA, Panguluri RK, Chen W et al (2001) Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans. Cancer Epidemiol Biomarkers Prev 10:943-947
16. Kwabi-Addo B, Chung W, Shen L et al (2007) Agerelated DNA methylation changes in normal human prostate tissues. Clin Cancer Res 13:3796-3802
17. Kwabi-Addo B, Ren C, Ittmann M (2009) DNA methylation and aberrant expression of Sprouty1 in human prostate cancer. Epigenetics 4:54-61
18. Mishra DK, Chen Z, Wu Y et al (o J) Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells. Mol Cancer Ther 9:33-45
19. Nelson WG (2004) Prostate cancer prevention. J Nutr 134:3211-3212
20. Nelson WG, De Marzo AM, Yegnasubramanian S (2009) Epigenetic alterations in human prostate cancers. Endocrinology 150:3991-4002
21. Nelson WG, Deweese TL, Demarzo AM (2002) The diet, prostate inflammation, and the development of prostate cancer. Cancer Metastasis Rev 21:3-16
22. Nelson WG, Wilding G (2001) Prostate cancer prevention agent development: Criteria and pipeline for candidate chemoprevention agents. Urology 57:56-63
23. Nelson WG, Yegnasubramanian S, Agoston AT et al (2007) Abnormal DNA methylation, epigenetics, and prostate cancer. Front Biosci 12:4254-4266
24. Noonan-Wheeler FC, Wu W, Roehl KA et al (2006) Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. Prostate 66:49-56
25. Nordstrom T, Ronaghi M, Forsberg L et al (2000) Direct analysis of single-nucleotide polymorphism on double-stranded DNA by pyrosequencing. Biotechnol Appl Biochem 31(2):107-112
26. Robertson KD, Jones PA (2000) DNA methylation: past, present and future directions. Carcinogenesis 21:461-467
27. Rodriguez-Canales J, Hanson JC, Tangrea MA et al (2007) Identification of a unique epigenetic submicroenvironment in prostate cancer. J Pathol 211:410-419
28. Ronaghi M, Nygren M, Lundeberg J et al (1999) Analyses of secondary structures in DNA by pyrosequencing. Anal Biochem 267:65-71
29. Ross SA (2003) Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 983:197-207
30. Ruscoe JE, Rosario LA, Wang T et al (2001) Pharmacologic or genetic manipulation of glutathione Stransferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298:339-345
31. Schulz WA, Hoffmann MJ (2009) Epigenetic mechanisms in the biology of prostate cancer. Semin Cancer Biol 19:172-180
32. Song MA, Park JH, Jeong KS et al (2007) Quantification of CpG methylation at the 5′-region of XIST by pyrosequencing from human serum. Electrophoresis 28:2379-2384
33. Tost J, Dunker J, Gut IG (2003) Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 35:152-156
34. Tost J, Gut IG (2007) DNA methylation analysis by pyrosequencing. Nat Protoc 2:2265-2275
35. Wang LG, Beklemisheva A, Liu XM et al (2007) Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol Carcinog 46:24-31